In a joint letter to Treasurer Jim Chalmers, 17 industry organisations called for consultation on two RDTI changes announced ...

The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...

To date, the company has raised over $34 million from investors and operates a 15-person team at facilities at Johns Hopkins Medical Campus.

In an interview, synthetic biologist Peter Carr explains research on synthetic cells, their potential benefits and hazards, ...

This cell-like structure can grow, feed, divide and compete. Researchers ponder what it means for the future of synthetic ...

Preclinical realities, therapeutic momentum, and generative AI in drug discovery ...

New research shows it’s possible to edit the DNA of human embryos with more precision. But scientists warn it’s still not ...

With a lifelong passion for baseball and love of science, Jake Bruml began his career in biotech but transitioned to direct ...

Embedded in the boundary between the inside and outside of each cell are membrane proteins. They act as first responders by ...

The conversation around menopause in Canada is rapidly evolving from a niche health topic into a broader cultural, workplace, ...

Special Judge Sushant Changotra granted one day’s custodial interrogation to CBI against its request for 5 days ...